Mobile Marketing Report: On Hold

It's not as though pharma marketers didn't see mobile coming. For the past half decade, they've discussed its potential to transform behaviors and relationships within ...

Therapeutic Focus: Rare Diseases

The rare disease drug market is making history with its steady growth and burgeoning pipeline—and owing to continuing breakthroughs in gene therapy, the biggest advances ...

Nothing (Im)personal

With unprecedented numbers of practices locking out sales reps, pharma companies are being forced to do a better job of engaging HCPs in other ways

Headliner: Scientist CEO sets sights on Sierra Leone

Thomas Sack, President and CEO, MRIGlobal

Latest

Researchers find payer discrimination

Researchers found that 25% of ACA-compliant plans put HIV drugs in the highest formulary tier.

Alexion, Treato shuffle staff

Alexion's CEO Leonard Bell is retiring, and TripAdvisor's Christine Peterson has joined Treato.

Five things for pharma marketers to know: Thursday, January 29

Five things for pharma marketers to know: Thursday, January 29

Former FDA chief tells court J&J knew of Risperdal risk, pay-for-delay deals get new court criteria, lawmakers may declare pharmacists healthcare providers.

Biogen adds football, basketball talent for MS campaign

Biogen adds football, basketball talent for MS campaign

MS drugmaker Biogen Idec drafted Tyler Campbell, son of NFL Hall of Fame running back Earl Campbell, and former Dallas Mavericks point guard Chris Wright to help inspire sufferers of multiple sclerosis.

Amgen, Novartis, BMS map future

Amgen, Novartis, BMS map future

Amgen execs assert there is still a future for 15-year-old Enbrel, Novartis sees off-label Avastin use pinch Lucentis sales and BMS has expanded its field force in anticipation of an Opdivo push.

Five things for pharma marketers to know: Wednesday, January 28

Five things for pharma marketers to know: Wednesday, January 28

Doximity professional network now includes financial data; Pfizer settles class-action lawsuit; researchers hope to use temporary tattoos to identify glucose levels.

Purdue's new Rx opioid hits market

Purdue's new Rx opioid hits market

Hysingla ER is ready for the marketplace, just two months after FDA approval.

Pfizer quarter and year sales slip, CEO indicates M&A not pressing

Pfizer quarter and year sales slip, CEO indicates M&A not pressing

CEO Ian Read told investors the company has cash to make a deal, but there is no urgent need.

P&G's Zzzquil accused of sexist tweet

The nighttime sleep aid's Twitter account wrote "Sleep LIKE he finally proposed," last week, a sentiment which didn't resonate positively with the feed's followers.

Drugmaker enlists Fitbit to better understand patients

Biogen Idec handed out 250 Fitbits last year to better understand how MS affects patients' mobility, and how its medications hinder disease progression.

Agency Spotlight


This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.

Email Newsletters